NABL, CAP, ISO
This assay is useful for predicting early recurrence in women treated for Carcinoma Breast. It is specially useful for serial testing in women with prior Stage II / III breast cancer who are clinically free of disease.
No special preparation required
With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a referenceRead More